BridgeBio Pharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
BridgeBio Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • BridgeBio Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 189M shares, a 15.4% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 163M shares, a 10.4% increase from 2022.
  • BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 147M shares, a 2.16% increase from 2021.
  • BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 144M shares, a 22.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 163M +15.3M +10.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 147M +3.12M +2.16% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 144M +26.4M +22.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 118M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.